Le Lézard
Classified in: Health
Subjects: HEALTH, MISCELLANEOUS

OPEN Health and Nested Knowledge announce strategic research collaboration to leverage AI technologies for evidence synthesis


London, Dec. 11, 2023 (GLOBE NEWSWIRE) -- London, UK ? December 11, 2023 ? OPEN Health, a preeminent global provider of consulting, HEOR and market access, patient engagement, and scientific and creative communications services, is excited to announce a strategic collaboration with Nested Knowledge, a leading provider of AI-based SaaS platform solutions for systematic literature review and meta-analysis. Together, we aim to enhance the speed, efficiency, and depth of evidence synthesis, ultimately aiding biopharmaceutical researchers in making crucial healthcare decisions and bringing products to market quicker.

"This collaboration underscores OPEN Health's unwavering commitment to leveraging innovative solutions and AI technologies for superior client delivery," said Richard Jones, President of OPEN Health Evidence & Access. "We are excited to formalize our collaboration with Nested Knowledge and collectively bring market-leading evidence synthesis solutions to our clients."

Systematic literature reviews and meta-analyses facilitate the methodical evaluation of all pertinent research on a specific topic and are fundamental components of comprehensive outcomes assessments, often in preparation for health technology assessment (HTA) and reimbursement submissions. Boosting the speed and increasing the transparency at which they're conducted will hasten the translation of research into actionable insights and approved healthcare interventions. Nested Knowledge's AI-driven platform will be applied within OPEN Health's strategic market access and evidence synthesis teams, dramatically speeding up research analysis and the derivation of insights. By combining Nested Knowledge's technological prowess with OPEN Health's scientific and analytical expertise, the partnership aims to elevate the standards, speed, and precision of healthcare evidence analysis.

"Uniting technology with expertise is core to the mission of Nested Knowledge, as well as to overcoming key barriers in conventional evidence synthesis processes," according to Kevin Kallmes, CEO and founder of Nested Knowledge. "OPEN Health's leading evidence synthesis capabilities and approach to AI augmentation in the context of expert oversight makes them a perfect partner for scaling up more rapid, interactive, and technologically integrated solutions."

About OPEN Health

OPEN Health unites deep scientific knowledge with wide-ranging specialist expertise to unlock possibilities that improve health outcomes and patient well-being. Working in partnership with our clients, we embrace our different perspectives and strengths to deliver fresh thinking and solutions that make a difference. OPEN Health is a flexible global organization that solves complex healthcare challenges across consulting, HEOR and market access, scientific communications, patient engagement, and creative omnichannel communications. For more information on OPEN Health, visit www.openhealthgroup.com.

About Nested Knowledge

Nested Knowledge is a living evidence platform that houses, auto-extracts, and analyzes published clinical literature for conducting systematic literature reviews. As a result, each review produces evidence as interactive, web-based visuals. The platform emphasizes updateability, traceability, and visual interactivity?revolutionizing the way evidence is understood without depending on scattered, non-updatable, incomplete PDF outputs. For more information, visit https://about.nested-knowledge.com

Press contact:

OPEN Health

Candice Subero, [email protected]

Nested Knowledge

Keith Kallmes, [email protected]

Attachment



These press releases may also interest you

at 15:25
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced results from a new analysis of the ATLAS trial, which estimates using Kaplan Meier...

at 11:55
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the results of a sub-analysis from a real-world patient cohort review of JELMYTO...

at 09:00
Women's Heart Health Month is recognized every May and is focused on raising awareness about cardiovascular health among women. It aims to educate women about the risks, symptoms, and prevention of heart disease, which is the leading cause of death...

at 07:56
RaySearch Laboratories AB (publ) and C-RAD are pleased to announce a collaboration agreement, aiming at jointly developing innovative solutions and products to enhance the quality of radiation therapy. The focus of the collaboration is to...

at 06:00
SecondOpinionExpert, Inc. (SOE), a leading healthcare technology company, announced today that OC Fertility® + OC Biogenix® located in Newport Beach, Orange County, California will join SOE's expert panel to provide second opinions for fertility...

at 05:00
Scientology Network's VOICES FOR HUMANITY, the weekly series presenting heroic change makers from a variety of faiths, cultures and nations, working to uplift their communities, announces a new episode featuring anti-drug activist Robert Galibert....



News published on and distributed by: